Kahira Pharmaceuticals

Last Updated:
  • 36.56 EGP
  • 1.26
  • 3.57%
القاهرة للادوية والصناعات الكيماوية
القاهرة للادوية
Symbol : CPCI
ISIN : EGS38391C016
52-Week Range : 25.60 - 39.79
Turnover Ratio : 0.12
Market : Egyptian Exchange
Sector : Health Care & Pharmaceuticals
Industry : Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :

Kahira Pharmaceuticals Profile

Basic Information

  • Activity :
    Kahira Pharmaceuticals is a public company, listed on Egyptian Exchange (EGX) since April 1996. It operates within the pharmaceuticals, biotechnology and life sciences sector focusing on pharmaceuticals....
  • Industry Group :
    pharmaceuticals Research and Biotechnology
  • Sub-Industry :
  • ISIN :
    EGS38391C016
  • Contact Person :
  • Established On:
    20-Jul-1991
  • Stock Listing On :
    09-Apr-1996
  • No of Employees :
    2,280 Employees as of 2021
  • Outstanding Shares :
    14,934,375
  • Free Float Shares :
  • Par Value :
  • Paid Capital :
  • Market Cap :
    527.18 M EGP
  • Authorized Capital :

Indices Membership

Action Date Index Provider
Join 2020 Health Care & Pharmaceuticals Egyptian Exchange
Leave 2010 EGX 70 Egyptian Exchange
Join 2010 EGX 70 Egyptian Exchange
Join 1996 Egyptian Exchange
Kahira Pharmaceuticals
4 Abdel Hamid Al-Dib St., Victoria Square, Shubra
T : +20 2 22022459
F : +20 2 22025477
info@kahirapharma.com.eg

Management

Title Name As Of
Chairman: Adel Abdel Wahab
Managing Director: Yasser Mohamed
Board Member: Salem Gaballah 2021
Dina El Kayyali
Mohamed Metwally 2018

Reports

Date Title File
Kahira Pharmaceuticals Quarterly Financials Report Q1 2021
Kahira Pharmaceuticals Annual Financials Report 2020
Kahira Pharmaceuticals Quarterly Financials Report Q3 2020
Kahira Pharmaceuticals Quarterly Financials Report Q2 2020
Kahira Pharmaceuticals Quarterly Financials Report Q1 2020
Kahira Pharmaceuticals Annual Financials Report 2019
Kahira Pharmaceuticals Quarterly Financials Report Q3 2019
Kahira Pharmaceuticals Quarterly Financials Report Q2 2019
Kahira Pharmaceuticals Quarterly Financials Report Q1 2019
Release from the company concerning the amendment in the Audit Committee
Kahira Pharmaceuticals Annual Financials Report 2018
Check our coverage for Egypt